Zero Trust Is Not a Product — It’s a Mindset Shift in Digital Security

For years, cybersecurity was built around a simple assumption: once inside the network, you were trusted. That assumption no longer holds. Today’s organizations operate in hybrid environments, with employees working remotely, applications running across multiple clouds, APIs connecting partners, and services communicating autonomously. The traditional perimeter has dissolved. In this new reality, trust cannot be…

Read More

How to Scale Peptide Manufacturing Without Running Into Pitfalls

Peptide therapeutics have surged as vital treatments for conditions like diabetes, obesity, cancer, and metabolic disorders. This growth, with over 200 peptides in clinical trials today, and the rise of GLP‑1 drugs have created unprecedented demand for peptide APIs. In response, biopharmas and CDMOs alike are investing heavily in new facilities and equipment such as…

Read More

5 Ways Pharmaceutical CDMOs are Revolutionizing Drug Development and Manufacturing

In the pharmaceutical industry, Contract Development and Manufacturing Organizations (CDMOs) have emerged as pivotal partners, fundamentally transforming the drug development and manufacturing process. By offering end-to-end services from early drug development through commercial production, CDMOs streamline operations and accelerate timelines, enabling faster, more efficient, and cost-effective drug production. This article examines how pharmaceutical CDMOs are…

Read More